References
- Ahn, J., Jeong, K.J., Ko, M., Shin, H.J., Chung, H.J., and Jeong, H. (2009). High-concentration Epigallocatechin gallate treatment causes endoplasmic reticulum stress-mediated cell death in HepG2 cells. Genomics inform. 7, 97-106. https://doi.org/10.5808/GI.2009.7.2.097
- Baycol website. Dear healthcare Letter Baycoll pull.jpg http://www.baycol.com/.
- Bharadwaj, D., Stein, M.P., Volzer, M., Mold, C., and Du Clos, T.W. (1999). The major receptor for C-reactive protein on leukocytes is fcgamma receptor. J. Exp. Med. 16, 585-590.
- Bolego, C., Baetta, R., Bellosta, S., Corsini, A., and Paoletti, R. (2002). Safety Considerations for statins. Curr. Opin. Lipidol. 13, 637-644. https://doi.org/10.1097/00041433-200212000-00007
- Chalasani, N. (2005). Statins and Hepatotoxicity: Focus on patients with fatty liver. Hepatology 41, 690-695. https://doi.org/10.1002/hep.20671
- Dold, S., Laschke, M.W., Lavasani, S., Menger, M.D., Jeppsson, B., and Thorlacius, H. (2009). Simvastatin protects against cholestasis-induced liver injury. Br. J. Pharmacol. 156, 466-474. https://doi.org/10.1111/j.1476-5381.2008.00043.x
- Hamelin, B.A., and Turgeon, J. (1998). Hydrophilicity/lipophilicity: relevance fro the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol. Sci. 19, 26-37. https://doi.org/10.1016/S0165-6147(97)01147-4
- Hart, S.N., Li, Y., Nakamoto, K., Subileau, E.A., Steen, D., and Zhong, X.B. (2010). A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Drug Metab. Dispos. March 12, [Epub ahead of print] https://doi.org/10.1124/dmd.109.031831
- Heart protection study collaborative group. (2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 360, 7-22. https://doi.org/10.1016/S0140-6736(02)09327-3
- Hsu, C.C., Lin, C.C., Liao, T.S., and Yin, M.C. (2006). Protective effect of s-allyl cysteine and s-propyl cysteine on acetaminophen-induced hepatotoxicity in mice. Food Chem. Toxicol. 44, 393-397. https://doi.org/10.1016/j.fct.2005.08.012
- Johnston, B., Burns, A.R., Suematsu, M., Issekutz, T.B., Woodman, R.C., and Kubes, P. (1999). Chronic inflammation upregulates chemokine receptors and induces neutrophil migration to monocyte chemoattractant protein-1. J. Clin. Invest. 10, 1269-1276.
- Kanehisa, M., and Goto, S. (2000). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucl. Acids Res. 28, 27-30. https://doi.org/10.1093/nar/28.1.27
-
Luebke-Wheeler, J., Zhang, K., Battle, M., Si-Tayeb, K., Garrison, W., Chhinder, S., Li, J., Kaufman, R.J., and Duncan, S.A. (2008). HNF4
${\alpha}$ is implicated in ER stress induced acute phase response by regulating expression of CrebH. Hepatology 48, 1242-1250. https://doi.org/10.1002/hep.22439 - Maddrey, W.C. (2005). Drug-induced hepatotoxicity. J. Clin. Gastroenterol. 39, S83-S89. https://doi.org/10.1097/01.mcg.0000155548.91524.6e
- Maitland-van der Zee, A.H., Peters, B.J., Lynch, A.I., Boerwinkle, E., Arnett, D.K., Cheng, S., Davis, B.R., Leiendecker-Foster, C., Ford, C.E., and Eckfeldt, J.H. (2009). The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13) on the effectiveness of statins: the GenHAT study. Pharmacogenet. Genomics 19, 338-344. https://doi.org/10.1097/FPC.0b013e32832933b7
- Mi, H., Lazareva-Ulitsky, B., Loo, R., Kejariwal, A., Vandergriff, J., Rabkin, S., Guo, N., Muruganujan, A., Doremieux, O., Campbell, M.J., Kitano, H., and Thomas, P.D. (2005). The PANTHER database of protein families, subfamilies, functions and pathways. Nucl. Acids Res. 33, D284-D288. https://doi.org/10.1093/nar/gki418
- Stein, E., Sprecher, D., Allenby, K.S., Tosiello, R.L., Whalen, E., and Ripa, S.R. (1997). Cerivastatin, a new potent synthetic HMG-CoA reductase inhibitor: Effect of 0.2mg daily in subjects with primary hypercholesterolemia. J. Cardiovasc. Pharmacol. Ther. 2, 7-16. https://doi.org/10.1177/107424849700200102
- Vasudevan, A.R., Hamirani, Y.S., and Jones, P.H. (2005). Safety of statins: effect on muscle and the liver. Cleve. Clin. J. Med. 72, 990-993. https://doi.org/10.3949/ccjm.72.11.990
- Wilmshurst, P. (2002). Heart Protection Study. Lancet. 2003 Feb 8;361, 528-529 author reply 529-530. https://doi.org/10.1016/S0140-6736(03)12472-5
- Yamazaki, H., Suzuki, M., Alki, T., Morikawa, S., Maejima, T., and Sato, F. (2006). Influence of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors of ubiquinone level in rat skeletal muscle and heart: relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cell. J. Atheroscler. Thromb. 13, 295-307. https://doi.org/10.5551/jat.13.295
- Zannis, V.I., Kan, H.Y., Kritis, A., Zanni, E., and Kardassis, D. (2001) .Transcriptional regulation of the human apolipoprotein genes. Front. Biosci. 1, 456-504.
Cited by
- Atorvastatin up-regulate toxicologically relevant genes in rainbow trout gills vol.21, pp.7, 2012, https://doi.org/10.1007/s10646-012-0918-z